Last reviewed · How we verify
SSRI Active
At a glance
| Generic name | SSRI Active |
|---|---|
| Sponsor | Euthymics BioScience, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of Maintenance of the Efficiency and Adverse Effects of Pharmacological Treatments in Sex Offenders With Paraphilia (NA)
- Predicting SSRI Efficacy in Veterans With PTSD (PHASE4)
- Improving Outcomes in Depression in Primary Care in a Low Resource Setting (PHASE3)
- Efficacy and Safety of Low-dose Laser Acupuncture on Treating Insomnia Associated With Major Depressive Disorder (NA)
- A Study on Functional Connectome and rTMS Intervention of Cognitive Flexibility Impairment in Patients With Major Depressive Disorder (NA)
- Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia (PHASE3)
- Disposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in Nigeria (PHASE4)
- Quetiapine for Bipolar Disorder and Alcohol Dependence (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SSRI Active CI brief — competitive landscape report
- SSRI Active updates RSS · CI watch RSS
- Euthymics BioScience, Inc. portfolio CI